Published Date: 26 Apr 2023
The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.
Read Full NewsVistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage trial testing its ability to reduce symptoms in...
Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.
1.
Charting the Course: From Young Adult Leukemia Patient to Oncologist.
2.
The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.
3.
Early detection of breast cancer may be possible with AI-based mammography microcalcification detection and classification.
4.
According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late
2.
Survivorship and Quality of Life in Modern Oncology Care
3.
Landmark Medical Oncology Trials Redefining Early Breast Cancer Management
4.
Organoids & Single-Cell Tools: Breakthroughs in Colorectal Cancer Research
5.
Harnessing Snake Venom in Hematology: From Toxins to Life-Saving Therapeutics
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
5.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation